Company intelligence / Profile preview

Alessa Therapeutics

San Carlos, California, United Statesalessatherapeutics.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Alessa has initiated first-in-human Phase I studies of its Enolen® implant for localized sustained delivery of enzalutamide in prostate cancer patients. Early feasibility testing with the Biolen® system has been completed. The company’s approach aims to deliver anti-androgen therapy directly to the prostate, potentially reducing systemic side effects seen with current therapies. Initial data from ongoing trials are expected soon.[3][5][10]

Therapeutic areas: Men's HealthOncology
Modalities: Drug-eluting implants (localized sustained drug delivery)Small molecules (anti-androgens such as enzalutamide and bicalutamide)[1][3][7]
Industry: Biotech

Drug pipeline

7 assets

IND 2H/26

Preclinical

6 more assets in the full pipeline.

Request access →

Partnerships

National Cancer Institute / NIH – collaboration on clinical studies including first-in-human trial of Enolen and Biolen systems[5][9]Johnson & Johnson Innovation – JJDC, Inc. – investor and board representation through venture arm participation[3]

Beyond the preview

Go deeper on Alessa Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alessa Therapeutics.

Explore the full profile